(Q34554776)

3 August 2017

Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis (English)

1 reference

Mycobacterium tuberculosis

3 August 2017

0 references

1 reference

0 references

Ha SJ

1

1 reference

3 August 2017

Jeon BY

2

1 reference

3 August 2017

Youn JI

3

1 reference

3 August 2017

Kim SC

4

1 reference

3 August 2017

Cho SN

5

1 reference

3 August 2017

Sung YC

6

1 reference

3 August 2017

1 April 2005

1 reference

3 August 2017

1 reference

3 August 2017

12

1 reference

3 August 2017

7

1 reference

3 August 2017

634-638

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302465

3 August 2017

0 references

cites work

Immunology of tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

Global burden of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

Is the development of a new tuberculosis vaccine possible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

The action of antituberculosis drugs in short-course chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

Vaccination against tuberculosis by DNA injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

DNA immunization in a mouse model of latent tuberculosis: effect of DNA vaccination on reactivation of disease and on reinfection with a secondary challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

Pulmonary necrosis resulting from DNA vaccination against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

Therapy of tuberculosis in mice by DNA vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

Reactivation of latent tuberculosis by an inhibitor of inducible nitric oxide synthase in an aerosol murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

DNA vaccine strategies: candidates for immune modulation and immunization regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

Optimization of DNA vaccination against cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

Improved tuberculosis DNA vaccines by formulation in cationic lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

Induction of in vivo functional Db-restricted cytolytic T cell activity against a putative phosphate transport receptor of Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

Efficient induction of T helper 1 CD4+ T-cell responses to hepatitis C virus core and E2 by a DNA prime-adenovirus boost.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

IL-23 induces stronger sustained CTL and Th1 immune responses than IL-12 in hepatitis C virus envelope protein 2 DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

Molecular epidemiology of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

The immunogenicity of single and combination DNA vaccines against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

inferred from DOI database lookup

7 January 2021

based on heuristic

CD4+ T cells contain Mycobacterium tuberculosis infection in the absence of CD8+ T cells in mice vaccinated with DNA encoding Ag85A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

inferred from DOI database lookup

7 January 2021

based on heuristic

Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302465

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302465

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference